Continuing the expansion of its Intellectual Property Practice and life sciences capabilities, Mintz, Cohn, Ferris, Glovsky & Popeo, P.C. announced that Kenneth E. Jenkins has joined the firm as a Member in San Diego. He comes to Mintz from Kilpatrick Townsend & Stockton, where he served as Managing Partner of the San Diego office.
“Ken is a tremendous addition to the deep bench of IP attorneys we have here in San Diego and across the firm who are working with clients that are developing breakthroughs in life sciences and other cutting-edge technologies,” said Eddie Wang Rodriguez, Managing Member of the San Diego office and a member of Mintz Policy Committee. “He is well-known and highly regarded among many of the region’s top companies and research institutions. We are delighted to welcome him to the San Diego office and to the firm.”
In recent months, Mintz has added more than two dozen IP attorneys.
“Demand for demonstrated expertise in IP prosecution continues to grow,” said Michael T. Renaud, Division Head for the Intellectual Property Section and also a member of the firm’s Policy Committee. “We are fortunate to be able to continue to attract high quality laterals like Ken who bring extensive experience and deep knowledge of the marketplace.”
Mr. Jenkins, who holds a Ph.D. in Chemistry and Biochemistry, specializes in patent counseling and procurement in the health and life sciences sectors. His experience spans a wide array of technologies including pharmaceuticals, diagnostics, small molecule therapeutics, stem cell therapies, antibody therapeutics and petrochemical technologies.
Mr. Jenkins works closely with both corporations and research institutions to develop patent claiming and filing strategies; procure patents on cornerstone technologies; and strategically manage patent portfolios to maximize investments. He counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom to operate analyses and in-licensed technology investigations. He also provides strategic advice in high-stakes patent litigations involving challenges under the Hatch-Waxman Act.
Mr. Jenkins earned his Ph.D. from the University of Colorado. He also holds a J.D. from the University of California’s Hastings College of Law and a B.S. in Biochemistry from the University of Texas. He has received numerous top honors, including the Royal Society of Chemistry’s Young Investigator Award, and has been named a top patent attorney by several publications including Super Lawyers magazine, the San Diego Business Journal and IAM Patent 1000.